...-DLBCL三组标本和Hans免疫组化分析后在蛋白水平分为GCB和Non-GCB二组标本,分别统计各组病例的无病生存率(Disease-free survival,DFS),应用Kaplan-Meier方法分别进行生存分析,分子分型GCB-DLBCL ABC-DLBCL和...
基于4个网页-相关网页
患者的无病生存率 disease-free survival
者有更好的无病生存率 disease-free survival
的8年无病生存率 disease-free survival ; DFS
的术后无病生存率 disease-free survival
的6年以上无病生存率 disease-free survival ; DFS
的5年无病生存率 disease-free survival
患儿的术后无病生存率 disease free survival
柳叶刀上有报道说如果供者的血和病人的匹配很好，那么两种方法的白血病的无病生存率很相近。
If the donor blood was well matched to the patient, the rate of leukemia-free surial was similar in both methods, according to the findings published in The Lancet.
观察两组患者的临床疗效、组织学疗效、对化疗的毒副反应，以及术后3年生存率和无病存活率，并进行对比分析。
The clinical and histological effects, toxic and side reaction of chemotherapy such as nausea and vomit, the 3-year survival rates and disease-free survival rates were analyzed.
结论MAE方案可提高老年aml的缓解率和长期无病生存率。
Conclusion MAE protocol can improve CR rate in elderly patients of AML.
应用推荐